PP
IRMD icon

PDT Partners’s iRadimed IRMD Stock Holding History

PDT Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Sell
2,404
-8,129
-77% -$740K 0.01% 462
2026
Q1 		$1.01M Buy
+10,533
New +$1.05M 0.06% 341
2022
Q1 		– Sell
-4,631
Closed -$214K – 1014
2021
Q4 		$214K Buy
+4,631
New +$187K 0.02% 753
2020
Q2 		– Sell
-9,738
Closed -$208K – 739
2020
Q1 		$208K Buy
+9,738
New +$232K 0.02% 556

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PDT Partners's IRMD Position: Q2 2026 in Review

PDT Partners reduced its iRadimed (IRMD) stake by 77% in Q2 2026, selling an estimated $740K and leaving 2,404 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #462.

PDT Partners first reported a position in IRMD in Q1 2020 and has held it in 4 quarters since. The position peaked at $1.01M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • PDT Partners held 2,404 shares of iRadimed worth $230K as of Q2 2026.
  • PDT Partners sold 8,129 iRadimed shares in Q2 2026, an estimated $740K.
  • iRadimed made up 0.01% of PDT Partners's portfolio in Q2 2026, its #462 holding.
  • PDT Partners first reported a position in iRadimed in Q1 2020 and has held it in 4 quarters since.
  • PDT Partners's iRadimed position peaked at $1.01M in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.